Article Text

Download PDFPDF
Lack of evidence on drugs to support benzodiazepine withdrawal

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

A Cochrane review that assessed pharmaceutical interventions to aid benzodiazepine withdrawal following long-term use and/or dependency was unable to draw conclusions on their efficacy and safety because of an absence of good quality evidence.1 The British National Formulary advises that benzodiazepines are indicated for the short-term relief (2-4 weeks only) of anxiety or insomnia that is severe, disabling or causing a person unacceptable distress.2 In 2015, there …

View Full Text